1.Effect of RAGE and its ligands on CD4 + T cells
Cui LYU ; Zhaohua HOU ; Yunbo WEI ; Jinhong FENG ; Yu DI
Chinese Pharmacological Bulletin 2015;(12):1652-1655
RAGE (receptor for advanced glycation end products) is a multiligand receptor on the cell surface.Ligand-RAGE inter-actions activate several signal transduction pathways that propa-gate cellular oxidative stress and inflammatory response.RAGE expressed on the CD4 + T cells has been identified as a central transduction receptor which affects the activation,proliferation, migration and differentiation of the cells.In addition,blockade of RAGE suppressed the development of multiple immune-related
disorders mediated by CD4 + T cells.These studies highlight the importance of RAGE and its ligands for CD4 + T cells.This arti-cle briefly reviews the role of RAGE and its ligands on the prolif-eration,migration and differentiation of CD4 + T cells and sum-marizes the related research progress.
2.Progress of N-myristoylation in oncology treatment
Yunbo DI ; Qingyu ZHANG ; Yueling WU ; Ying ZHANG
Cancer Research and Clinic 2023;35(12):957-960
N-myristoylation is a type of protein modification and one of the most common types of protein lipidation. N-myristoylation affects cell signal transduction and metabolic pathway reprogramming by changing protein conformation, stability and localization. It is involved in various physiological and pathological processes. Studies have shown that the protein N-myristoyltransferase (NMT) is abnormally expressed in many types of malignancies and involves in development and progression of tumors. Inhibitors targeting NMT have good anticancer effects and provide potential targets for cancer recurrence and metastasis therapy. This article mainly introduces the protein N-myristoylation system and reviews its role and mechanism in the development and progression of tumors, summarizes the latest research progress of targeting protein N-myristoylation for the treatment of cancer in the last 5 years.